LipoScience to Release Second Quarter 2014 Financial Results

        Print
| Source: LipoScience, Inc.

RALEIGH, N.C., Aug. 4, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its second quarter 2014 financial results after the market close on Tuesday, August 12, 2014. An investor conference call will follow on the same day at 4:30 P.M. ET.

The conference call will be hosted by Howard Doran, President and Chief Executive Officer and Lucy Martindale, Executive Vice President and Chief Financial Officer.

To participate in the call, please dial (877) 303-2523 (U.S. and Canada) or (253) 237-1755 (international). The Conference ID Number is 78879879. A live webcast will be available on the Investor Relations section of the corporate website at http://investor.liposcience.com.

A replay of the conference call will be available beginning August 12, 2014 at 7:30 P.M. ET and ending on August 26, 2014 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 78879879. A replay of the webcast will be available on the corporate website for two weeks, through August 26, 2014.

About LipoScience, Inc.

LipoScience, Inc. (Nasdaq:LPDX) is focused on developing diagnostic tests based on nuclear magnetic resonance (NMR) technology to improve the quality of patient care in cardiovascular, metabolic and other diseases. The NMR LipoProfile® test, the Company's first proprietary test, is an FDA-cleared, outcome proven, society endorsed blood test that directly quantifies LDL particles and provides physicians and their patients with actionable information to personalize management of heart disease. For further information on LipoScience, please visit www.liposcience.com

Media Contacts:

Tori Hall
LipoScience, Inc.
(919) 256-1046


Bob Yedid
ICR, Inc.
(646) 277-1250